n Southern African Journal of HIV Medicine - Levels of procalcitonin, C-reactive protein and neopterin in patients with advanced HIV-1 infection : original article
|Article Title||Levels of procalcitonin, C-reactive protein and neopterin in patients with advanced HIV-1 infection : original article|
|Journal||Southern African Journal of HIV Medicine|
|Affiliations||1 University of Pretoria, 2 University of Pretoria, 3 University of Pretoria and 4 Kalafong Hospital|
|Publication Date||Jun 2012|
|Pages||78 - 82|
Objectives. To compare the value of procalcitonin, C-reactive protein (CRP) and neopterin as indicators of immune deficiency, co-infection, efficacy of treatment, and disease progression, in patients with advanced HIV-1 infection.
Design. Cross-sectional, investigating baseline blood measurements and clinical observations in 82 HIV-positive patients divided into an antiretroviral treatment (ART) group and an ART-naïve group.
Setting. Secondary general hospital in Pretoria.
Results. Procalcitonin and CRP levels showed no significant differences between the ART and ART-naïve groups, and no correlations with CD4 counts or viral loads. CRP levels were significantly higher with TB co-infection (p<0.05). Neopterin levels were raised above normal in 92% of the ART-naïve group and in 75% of the ART group. The levels were significantly higher (p<0.05) in the ART-naïve group. Negative correlations were found between neopterin and CD4 counts for the total patient group (r=-0.482; p<0.001). Neopterin was significantly (p<0.05) higher in the HIV/TB co-infection group than in those without TB. Higher neopterin levels at baseline were associated with a decline in CD4 counts over the ensuing 6-month period, and patients with higher baseline neopterin levels developed more complications over the 6-month period.
Conclusions. Compared with procalcitonin and CRP, neopterin appears to be associated with the degree of immunodeficiency and of co-infection with TB. Neopterin levels may be investigated further as a measure of disease progression or treatment response.
Article metrics loading...